The Cardiopulmonary Applications course (SCC-6001) of the Advanced Stem Cell Education Program is designed to teach healthcare professionals how stem cell therapies have improved the treatment of cardiovascular ailments, asthma, pulmonary fibrosis, cystic fibrosis, hypertension, ARDS, and malignant mesothelioma.
According to the CDC, in the United States alone there are 7.1 million survivors of myocardial infarction (MI) and 4.9 million people living with congestive heart failure (CHF). Heart disease is the leading cause of death for both men and women in the United States. The incidence of heart failure leading to hospitalization, and its mortality rates continue to rise despite recent advances in medicine. For patients in the late stages of lung disease, transplantation is sometimes the only viable therapeutic option. However, organ availability is limited and rejection presents an additional challenge. Regenerative medicine aims to restore the function of failing organs and tissues for patients with serious injuries or chronic diseases such as cardiovascular disorders and lung disease.
The use of regenerative medicine and stem cells in patients suffering from cardiovascular disorders or lung disease has proven successful over the years and it is anticipated that these therapies will be further refined to improve success rates in the coming years.
• This is a subspecialty course with a cost of $2500.
• Self-paced open enrollment
• Physician CME Eligible: Yes: 33.5 CME AMA PRA Category 1 Credits™
• Program includes digital streaming of lectures and PDF resources
• Learn instantly with any computer or laptop with a strong internet connection
• Estimated effort: 6-7 weeks of material, 4-5 hours/week; 4 topic quizzes, final exam
Some background in biology is helpful. This course may contain discussion of unlabeled and/or investigational uses of agents not approved by the FDA. Please consult the prescribing information for each product.
• Biology Of Stem Cells
• Regulation of Stem Cell Therapies